Tamarack Capital Management as of Sept. 30, 2014
Portfolio Holdings for Tamarack Capital Management
Tamarack Capital Management holds 30 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 21.8 | $99M | 500k | 197.02 | |
| Endologix | 7.8 | $35M | 3.3M | 10.60 | |
| Spectranetics Corporation | 6.8 | $31M | 1.2M | 26.57 | |
| Medtronic | 5.1 | $23M | 370k | 61.95 | |
| CareFusion Corporation | 5.0 | $23M | 500k | 45.25 | |
| Greatbatch | 4.5 | $20M | 475k | 42.61 | |
| Auxilium Pharmaceuticals | 4.3 | $19M | 650k | 29.85 | |
| Alkermes (ALKS) | 4.3 | $19M | 450k | 42.87 | |
| Patterson Companies (PDCO) | 3.4 | $15M | 370k | 41.43 | |
| NxStage Medical | 3.2 | $14M | 1.1M | 13.13 | |
| MiMedx (MDXG) | 3.2 | $14M | 2.0M | 7.13 | |
| Philip Morris International (PM) | 2.8 | $13M | 150k | 83.40 | |
| Teva Pharmaceutical Industries (TEVA) | 2.7 | $12M | 230k | 53.75 | |
| Pfizer (PFE) | 2.6 | $12M | 400k | 29.57 | |
| Luminex Corporation | 2.4 | $11M | 550k | 19.50 | |
| RTI Biologics | 2.3 | $11M | 2.2M | 4.78 | |
| AtriCure (ATRC) | 2.3 | $10M | 700k | 14.72 | |
| Bio-Rad Laboratories (BIO) | 2.1 | $9.5M | 83k | 113.40 | |
| Natus Medical | 1.8 | $8.1M | 275k | 29.51 | |
| Cubist Pharmaceuticals | 1.6 | $7.3M | 110k | 66.34 | |
| Inogen (INGN) | 1.2 | $5.4M | 261k | 20.61 | |
| Volcano Corporation | 1.2 | $5.3M | 500k | 10.64 | |
| Streamline Health Solutions | 1.2 | $5.3M | 1.1M | 4.63 | |
| ICU Medical, Incorporated (ICUI) | 1.1 | $5.1M | 80k | 64.17 | |
| Imprivata | 1.0 | $4.7M | 300k | 15.52 | |
| Becton, Dickinson and (BDX) | 1.0 | $4.6M | 40k | 113.80 | |
| Dex (DXCM) | 0.9 | $4.2M | 105k | 39.99 | |
| Hanger Orthopedic | 0.9 | $4.1M | 200k | 20.52 | |
| Corium Intl | 0.9 | $4.1M | 668k | 6.14 | |
| Discovery Laboratories | 0.6 | $2.8M | 1.5M | 1.84 |
